Stockreport

DBV Technologies peanut allergy drug fails key study [Reuters]

DBV Technologies S.A. - American Depositary Shares  (DBVT) 
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF DBV Technologies peanut allergy drug fails key study | Reuters 2 Min Read Oct 20 (Reuters) - Drug developer DBV Technologies SA said on Friday its peanut allergy treatme [Read more]